日盈電子(603286.SH):韓亞偉擬減持不超3%股份
格隆匯12月9日丨日盈電子(603286.SH)公佈,截止本公告披露日,公司董事、監事、高級管理人員韓亞偉持有公司無限售條件流通股767.5萬股,佔公司總股本的8.7141%。
韓亞偉自公告披露之日起15個交易日後在連續90個自然日內通過集中競價交易的方式減持不超過88.076萬股,減持比例不超過公司總股本的1%。
韓亞偉自公告披露之日起3個交易日後在連續90個自然日內通過大宗交易的方式減持不超過176.152萬股,減持比例不超過公司總股本的2%。
上述通過兩種方式合計減持不超過264.228萬股,減持比例不超過公司總股本的3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.